Synthesis of radiolabelled aryl azides from diazonium salts: experimental and computational results permit the identification of the preferred mechanism

Real-Time High-Sensitivity Reaction Monitoring of Important Nitrogen-Cycle Synthons by 15N Hyperpolarized Nuclear Magnetic Resonance

Here, we show how signal amplification by reversible exchange hyperpolarization of a range of ¹⁵N-containing synthons can be used to enable studies of their reactivity by ¹⁵N nuclear magnetic resonance (NO₂^– (28% polarization), ND₃ (3%), PhCH₂NH₂ (5%), NaN₃ (3%), and NO₃^– (0.1%)). A range of iridium-based spin-polarization transfer catalysts are used, which for NO₂^– work optimally as an amino-derived carbene-containing complex with a DMAP-d₂ coligand. We harness long ¹⁵N spin-order lifetimes to probe in situ reactivity out to 3 × T₁. In the case of NO₂^– (T₁ 17.7 s at 9.4 T), we monitor PhNH₂ diazotization in acidic solution. The resulting diazonium salt (¹⁵N-T₁ 38 s) forms within 30 s, and its subsequent reaction with NaN₃ leads to the detection of hyperpolarized PhN₃ (T₁ 192 s) in a second step via the formation of an identified cyclic pentazole intermediate. The role of PhN₃ and NaN₃ in copper-free click chemistry is exemplified for hyperpolarized triazole (T₁ < 10 s) formation when they react with a strained alkyne. We also demonstrate simple routes to hyperpolarized N₂ in addition to showing how utilization of ¹⁵N-polarized PhCH₂NH₂ enables the probing of amidation, sulfonamidation, and imine formation. Hyperpolarized ND₃ is used to probe imine and ND₄⁺ (T₁ 33.6 s) formation. Furthermore, for NO₂^–, we also demonstrate how the ¹⁵N-magnetic resonance imaging monitoring of biphasic catalysis confirms the successful preparation of an aqueous bolus of hyperpolarized ¹⁵NO₂^– in seconds with 8% polarization. Hence, we create a versatile tool to probe organic transformations that has significant relevance for the synthesis of future hyperpolarized pharmaceuticals.

Radiochemistry: A Useful Tool in the Ophthalmic Drug Discovery

Positron Emission Tomography (PET) and Single Photon Emission Computerized Tomography (SPECT) are ultra-sensitive, fully translational and minimally invasive nuclear imaging techniques capable of tracing the spatiotemporal distribution of positron (PET) or gamma (SPECT) emitter-labeled molecules after administration into a living organism. Besides their impact in the clinical diagnostic, PET and SPECT are playing an increasing role in the process of drug development, both during the evaluation of the pharmacokinetic properties of new chemical entities as well as in the proof of concept, proof of mechanism and proof of efficacy studies. However, they have been scarcely applied in the context of ophthalmic drugs. In this paper, the basics of nuclear imaging and radiochemistry are briefly discussed, and the few examples of the use of these imaging modalities in ophthalmic drug development reported in the literature are presented and discussed. Finally, in a purely theoretical exercise, some labeling strategies that could be applied to the preparation of selected ophthalmic drugs are proposed and potential applications of nuclear imaging in ophthalmology are projected.

Chemistry for Positron Emission Tomography: Recent Advances in 11 C-, 18 F-, 13 N-, and 15 O-Labeling Reactions

Positron emission tomography (PET) is a molecular imaging technology that provides quantitative information about function and metabolism in biological processes in vivo for disease diagnosis and therapy assessment. The broad application and rapid advances of PET has led to an increased demand for new radiochemical methods to synthesize highly specific molecules bearing positron-emitting radionuclides. This Review provides an overview of commonly used labeling reactions through examples of clinically relevant PET tracers and highlights the most recent developments and breakthroughs over the past decade, with a focus on 11 C, 18 F, 13 N, and 15 O.

The microwave-assisted synthesis of 5-substituted 1H-tetrazoles via [3+2] cycloaddition over a heterogeneous Cu-based catalyst: application to the preparation of 13N-labelled tetrazoles

The [3+2] cycloaddition between various nitriles and sodium azide proceeds smoothly in the presence of a new Cu^II catalyst in N-methyl-2-pyrrolidone (NMP) to give the corresponding 5-substituted 1H-tetrazoles.

Synthesis of 13N-labelled polysubstituted triazoles via Huisgen cycloaddition

¹³N-labelled triazoles have been synthesized via Huisgen cycloaddition by reaction of ¹³N-labelled azides with alkynes or aldehydes under catalytic conditions.